Back to Search
EDWARD HORTON, M.D.
M.D.
Endocrinology, Diabetes & Metabolism Physician
NPI: 1003971730Individual
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
77268(MA)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Defining the role of basal and prandial insulin for optimal glycemic control.
PMID 19179213·J Am Coll Cardiol·2009
6-review
Efficacy and tolerability of initial combination therapy with nateglinide and metformin in treatment-naïve patients with type 2 diabetes.
PMID 15200747·Curr Med Res Opin·2004
3-trial
Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.
PMID 11092289·Diabetes Care·2000
3-trial
Correlates of dietary intake among men involved in the MAN for Health study.
PMID 19477748·Am J Mens Health·2009
8-other
Translocation (10;14)(q24;q32) as the sole chromosomal abnormality in a metastatic follicular thyroid carcinoma.
PMID 19264233·Cancer Genet Cytogenet·2009
5-case
Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance.
PMID 18083792·Diabetes Care·2008
8-other
Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program.
PMID 18356403·Diabetes Care·2008
4-observational
Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists.
PMID 18996826·Endocr Pract·2008
8-other
Value of urinary albumin-to-creatinine ratio as a predictor of type 2 diabetes in pre-diabetic individuals.
PMID 18796622·Diabetes Care·2008
8-other
The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.
PMID 18755353·J Am Coll Cardiol·2008
2-rct
Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline.
PMID 18664543·J Clin Endocrinol Metab·2008
6-review
Racial differences in the effects of age of onset on alcohol consumption and development of alcohol-related problems among males from mid-adolescence to young adulthood.
PMID 17430813·J Ethn Subst Abuse·2007
4-observational
Progress in the treatment of type 2 diabetes: new pharmacologic approaches to improve glycemic control.
PMID 17407648·Curr Med Res Opin·2007
6-review
We have the evidence, we need to act to improve diabetes care.
PMID 17991186·Int J Clin Pract Suppl·2007
6-review
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial.
PMID 17363746·Diabetes Care·2007
4-observational
The role of glucose as an independent cardiovascular risk factor.
PMID 17254517·Curr Diab Rep·2007
6-review
Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility.
PMID 17182639·Occup Environ Med·2007
8-other
A clonal t(8;12)(p11.2;q24.3) as the sole abnormality in a solitary fibrous tumor of the pleura.
PMID 17175385·Cancer Genet Cytogenet·2007
5-case
Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program.
PMID 17536077·Diabetes Care·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 JOSLIN PL
BOSTON, MA 02215 - Phone
- (617) 309-2400
Quick Facts
- NPI
- 1003971730
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile